By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Omnicell, Inc.

Omnicell, Inc. (OMCL)

NASDAQ Currency in USD
$379.00
+$2.58
+0.69%
Last Update: 18 Jul 2026, 14:26
$17.42bn
Market Cap
851.88
P/E Ratio (TTM)
Forward Dividend Yield
$274.81-$468.04
52 Week Range

OMCL Stock Price Chart

Explore Omnicell, Inc. interactive price chart. Choose custom timeframes to analyze OMCL price movements and trends.

OMCL Company Profile

Discover essential business fundamentals and corporate details for Omnicell, Inc. (OMCL) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Equipment & Services

IPO Date

7 Aug 2001

Employees

3.58k

CEO

Randall A. Lipps

Description

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

OMCL Financial Timeline

Browse a chronological timeline of Omnicell, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 30 Jul 2026

EPS estimate is $0.48, while revenue estimate is $310.25m.

Earnings released on 28 Apr 2026

EPS came in at $0.55 surpassing the estimated $0.33 by +66.67%, while revenue for the quarter reached $309.88m , beating expectations by +1.93%.

Earnings released on 5 Feb 2026

EPS came in at $0.40 falling short of the estimated $0.47 by -14.89%, while revenue for the quarter reached $313.98m , beating expectations by +0.20%.

Earnings released on 30 Oct 2025

EPS came in at $0.51 surpassing the estimated $0.36 by +41.67%, while revenue for the quarter reached $310.63m , beating expectations by +5.09%.

Earnings released on 31 Jul 2025

EPS came in at $0.45 surpassing the estimated $0.31 by +45.16%, while revenue for the quarter reached $290.56m , beating expectations by +5.56%.

Earnings released on 6 May 2025

EPS came in at $0.26 surpassing the estimated $0.16 by +62.50%, while revenue for the quarter reached $269.67m , beating expectations by +3.74%.

Earnings released on 6 Feb 2025

EPS came in at $0.60 surpassing the estimated $0.57 by +5.26%, while revenue for the quarter reached $306.88m , beating expectations by +3.02%.

Earnings released on 30 Oct 2024

EPS came in at $0.56 surpassing the estimated $0.41 by +36.59%, while revenue for the quarter reached $282.42m , missing expectations by -5.19%.

Earnings released on 1 Aug 2024

EPS came in at $0.51 surpassing the estimated $0.16 by +218.75%, while revenue for the quarter reached $276.79m , beating expectations by +8.46%.

Earnings released on 2 May 2024

EPS came in at $0.03 surpassing the estimated -$0.08 by +137.50%, while revenue for the quarter reached $246.15m , beating expectations by +3.97%.

Earnings released on 8 Feb 2024

EPS came in at $0.33 surpassing the estimated $0.17 by +94.12%, while revenue for the quarter reached $258.85m , beating expectations by +1.29%.

Earnings released on 2 Nov 2023

EPS came in at $0.62 surpassing the estimated $0.45 by +37.78%, while revenue for the quarter reached $298.66m , beating expectations by +1.08%.

Earnings released on 1 Aug 2023

EPS came in at $0.57 surpassing the estimated $0.28 by +103.57%, while revenue for the quarter reached $298.97m , beating expectations by +5.06%.

Earnings released on 2 May 2023

EPS came in at $0.39 surpassing the estimated $0.07 by +457.14%, while revenue for the quarter reached $290.63m , beating expectations by +4.67%.

Earnings released on 28 Feb 2023

EPS came in at $0.33 surpassing the estimated $0.09 by +266.67%, while revenue for the quarter reached $297.67m , beating expectations by +3.66%.

Earnings released on 2 Nov 2022

EPS came in at $1.00 surpassing the estimated $0.94 by +6.38%, while revenue for the quarter reached $348.06m , missing expectations by -4.18%.

Earnings released on 4 Aug 2022

EPS came in at $0.84 falling short of the estimated $0.85 by -1.18%, while revenue for the quarter reached $331.39m , missing expectations by -2.38%.

Earnings released on 28 Apr 2022

EPS came in at $0.83 surpassing the estimated $0.71 by +16.90%, while revenue for the quarter reached $318.83m , beating expectations by +1.42%.

Earnings released on 14 Feb 2022

EPS came in at $0.92 falling short of the estimated $0.95 by -3.16%, while revenue for the quarter reached $311.03m , missing expectations by -0.02%.

Earnings released on 2 Nov 2021

EPS came in at $1.08 surpassing the estimated $0.91 by +18.68%, while revenue for the quarter reached $296.40m , beating expectations by +4.21%.

Earnings released on 29 Jul 2021

EPS came in at $0.97 surpassing the estimated $0.80 by +21.25%, while revenue for the quarter reached $272.74m , meeting expectations.

OMCL Stock Performance

Access detailed OMCL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run